FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL
|
Estimated average burden hours per response... | 0.5 |
|
|
(Print or Type Responses)
1. Name and Address of Reporting Person *
|
Clark James David |
|
2. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [CVS]
|
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
|
_____ 10% Owner
|
__X__ Officer (give title below)
|
_____ Other (specify below)
|
SVP, Cont & Chief Acct Officer
|
|
ONE CVS DRIVE |
3. Date of Earliest Transaction (Month/Day/Year) 04/01/2020 |
WOONSOCKET, RI 02895 |
4. If Amendment, Date Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
|
1.Title of Security (Instr. 3)
|
2. Transaction Date (Month/Day/Year)
|
2A. Deemed Execution Date, if any (Month/Day/Year)
|
3. Transaction Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 04/01/2020 |
| F |
| 681 (1) | D |
$58.34 | 11,321.2554 | D |
|
Common Stock (restricted) | 04/01/2020 |
| A |
| 7,713 (2) | A |
$58.34 | 20,204 | D |
|
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date (Month/Day/Year)
|
3A. Deemed Execution Date, if any (Month/Day/Year)
|
4. Transaction Code (Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)
|
6. Date Exercisable and Expiration Date (Month/Day/Year)
|
7. Title and Amount of Underlying Securities (Instr. 3 and 4)
|
8. Price of Derivative Security (Instr. 5)
|
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Option |
$58.34 | 04/01/2020 |
| A |
| 17,157 |
| 04/01/2021 (3) | 04/01/2030 | Common Stock | 17,157 |
$58.34 | 17,157 | D |
|
Stock Option |
$74.29 |
|
|
|
|
|
| 04/01/2015 (4) | 04/01/2021 | Common Stock | 5,350 |
| 5,350 | D |
|
Stock Option |
$102.26 |
|
|
|
|
|
| 04/01/2016 (5) | 04/01/2022 | Common Stock | 6,059 |
| 6,059 | D |
|
Stock Option |
$104.82 |
|
|
|
|
|
| 04/01/2017 (6) | 04/01/2023 | Common Stock | 7,044 |
| 7,044 | D |
|
Stock Option |
$78.05 |
|
|
|
|
|
| 04/03/2018 (7) | 04/03/2024 | Common Stock | 9,050 |
| 9,050 | D |
|
Stock Option |
$62.21 |
|
|
|
|
|
| 04/01/2019 (8) | 04/01/2025 | Common Stock | 7,513 |
| 7,513 | D |
|
Stock Option |
$54.19 |
|
|
|
|
|
| 04/01/2020 (9) | 04/01/2029 | Common Stock | 24,240 |
| 24,240 | D |
|
Reporting Owners
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Clark James David ONE CVS DRIVE WOONSOCKET, RI 02895 |
|
|
SVP, Cont & Chief Acct Officer |
|
Signatures
/s/ James D. Clark | |
04/03/2020 |
**Signature of Reporting Person | Date |
Explanation of Responses:
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards. |
(2) | Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2021. |
(3) | Option becomes exercisable in four equal annual installments, commencing 4/1/2021. |
(4) | Remaining options became exercisable in four equal annual installments beginning on 4/1/2015. |
(5) | Options became exercisable in four equal annual installments beginning on 4/1/2016. |
(6) | Options became exercisable in four equal annual installments beginning on 4/1/2017. |
(7) | Options became exercisable in four equal annual installments beginning on 4/3/2018. |
(8) | Options became exercisable in four equal annual installments, commencing 4/1/2019. |
(9) | Options became exercisable in four equal annual installments, commencing 4/1/2020. |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
|